Dr. Irena Butrimiene, MD
Claim this profileNational Neuromuscular Research Institute
Area of expertise
Myasthenia Gravis
Irena Butrimiene, MD has run 13 trials for Myasthenia Gravis. Some of their research focus areas include:
Chronic Inflammatory Demyelinating Polyradiculoneuropathy And Multifocal Motor Neuropathy
Irena Butrimiene, MD has run 7 trials for Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy.
Affiliated Hospitals
National Neuromuscular Research Institute
Visionary Investigators Network
Clinical Trials Irena Butrimiene, MD is currently running
Efgartigimod
for Antibody-Mediated Rejection
The purpose of this study is to assess the safety, tolerability, and efficacy of efgartigimod PH20 SC given by a prefilled syringe in participants with Antibody-Mediated Rejection (AMR) after kidney transplantation. After a screening period of up to 6 weeks, eligible participants will be randomized in a 1:1:1 ratio. The study drug will be administered subcutaneously while patients remain on their standard background immunosuppression therapy (tacrolimus, mycophenolate mofetil, steroids) during the treatment period (48 weeks). At the end of the treatment period, the participants will enter an observational/follow-up period (approximately 24 weeks). The participants will be in the study for up to 78 weeks.
Recruiting
0 awards
Phase 2
4 criteria
Efgartigimod Safety
for Myasthenia Gravis During Pregnancy
This is a multi-country, prospective safety study of pregnant women exposed to efgartigimod or efgartigimod PH20 SC any time within 25 days prior to conception or any time during pregnancy. Women exposed to efgartigimod or efgartigimod PH20 SC only during breastfeeding will also be eligible to enroll. Background rates of major congenital malformations (MCMs) will be obtained from populations within the same countries/regions as the countries/regions in which the efgartigimod or efgartigimod PH20 SC exposed pregnancies were reported.
Recruiting
1 award
N/A
2 criteria
More about Irena Butrimiene, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 53 trials as a Principal Investigator · 18 Active Clinical Trials
Treatments Irena Butrimiene, MD has experience with
- Efgartigimod PH20 SC
- Efgartigimod
- Efgartigimod PH20 SC
- Placebo
- Empasiprubart
- Efgartigimod IV
Breakdown of trials Irena Butrimiene, MD has run
Myasthenia Gravis
Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Thrombocytopenic Purpura
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Irena Butrimiene, MD specialize in?
Irena Butrimiene, MD focuses on Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy. In particular, much of their work with Myasthenia Gravis has involved AChR-Ab positive patients, or patients who are acetylcholine receptor.
Is Irena Butrimiene, MD currently recruiting for clinical trials?
Yes, Irena Butrimiene, MD is currently recruiting for 17 clinical trials in Austin Texas. If you're interested in participating, you should apply.
Are there any treatments that Irena Butrimiene, MD has studied deeply?
Yes, Irena Butrimiene, MD has studied treatments such as Efgartigimod PH20 SC, Efgartigimod, efgartigimod PH20 SC.
What is the best way to schedule an appointment with Irena Butrimiene, MD?
Apply for one of the trials that Irena Butrimiene, MD is conducting.
What is the office address of Irena Butrimiene, MD?
The office of Irena Butrimiene, MD is located at: National Neuromuscular Research Institute, Austin, Texas 78756 United States. This is the address for their practice at the National Neuromuscular Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.